By Francesco Guarascio BRUSSELS – Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co’s COVID-19 pill, under a landmark U.N.-backed…
The decision by the Covid-19 National Task Force not to include Covid antiviral drug molnupiravir in the national treatment protocol citing safety concerns, even as the drug finds place in…
SEOUL: South Korea on Thursday received its first supply of Pfizer’s antiviral Covid-19 pills to treat patients with mild or moderate symptoms. Health officials have described the Paxlovid pills as…
BENGALURU: Doctors have s topped prescribing new antiviral drug molnupiravir, rolled out on January 3 to treat Covid-19, after recent remarks by ICMR over the safety of the drug. Doctors…
A majority of Covid patients during this Omicron-driven surge of infections have so far shown mild symptoms that can be managed at home with symptomatic treatment, an AIIMS doctor said…
India will become the largest global hub for Covid-19 antiviral general drug production after the drug controller granted emergency-use authorisation to several pharmaceutical companies in the country to manufacture and…
Merck Sharp & Dohme (MSD) on Friday said its COVID antiviral molnupiravir has cut the risk of hospitalization or death in Phase 3 clinical trial with no observed safety concerns…
Some call the oral pill a game-changer, others say more data needed With the centre granting Emergency Use Authorisation (EUA) for the antiviral Covid-19 pill molnupiravir, experts in the city…
The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking to 12 the number of preventives and…
Mumbai: As countries try to bend the surging Omicron cases, which is considered to be three times more transmissible than the Delta variant, Molnupiravir the oral antiviral treatment for COVID-19…
